FIELD: drug formulation. SUBSTANCE: invention consists in that oral composition contains active component, preferably base-sensitive selegeline, and sparkling base containing one or more alkali-earth metal carbonates, food organic acid and/or alkali metal citrate, and a pharmaceutically acceptable neutral adjuvant. EFFECT: facilitated administration of drug. 18 cl, 3 dwg, 11 ex
Authors
Dates
2004-01-20—Published
1999-03-20—Filed